TABLE 3.
Dosimetric parameters of all plans.
| Parameter | n | Clinical | KBPFull | KBP101 | KBP50 | KBP25 | KBPA | KBPB |
|---|---|---|---|---|---|---|---|---|
| Conformity Index | 39 | 1.090 ± 0.076 | 1.054 ± 0.065 | 1.057 ± 0.065 | 1.049 ± 0.066 | 1.050 ± 0.067 | 1.053 ± 0.025 | 1.057 ± 0.066 |
| Homogeneity Index | 39 | 0.073 ± 0.039 | 0.077 ± 0.025 | 0.078 ± 0.025 | 0.075 ± 0.024 | 0.076 ± 0.025 | 0.077 ± 0.025 | 0.078 ± 0.026 |
| Body V100% [%] | 39 | 1.102 ± 0.809 | 1.061 ± 0.777 | 1.064 ± 0.781 | 1.056 ± 0.777 | 1.058 ± 0.781 | 1.081 ± 0.775 | 1.065 ± 0.782 |
| Body V50% [%] | 39 | 10.37 ± 3.33 | 9.45 ± 2.91 | 9.48 ± 2.91 | 9.45 ± 2.84 | 9.37 ± 2.81 | 9.19 ± 2.83 | 9.44 ± 2.91 |
| Body V20% [%] | 39 | 25.08 ± 5.70 | 24.42 ± 5.61 | 24.51 ± 5.62 | 24.42 ± 5.64 | 24.38 ± 5.54 | 24.44 ± 5.60 | 24.50 ± 5.65 |
| Body V5% [%] | 39 | 40.43 ± 7.81 | 39.95 ± 7.70 | 39.93 ± 7.71 | 39.85 ± 7.74 | 39.84 ± 7.81 | 39.94 ± 7.65 | 39.96 ± 7.68 |
| PTV High DMax [%] | 39 | 110.1 ± 2.2 | 110.3 ± 1.7 | 110.4 ± 1.9 | 110.1 ± 1.9 | 110.6 ± 2.3 | 110.1 ± 2.0 | 110.4 ± 1.9 |
| PTV High V105% [%] | 39 | 12.5 ± 18.7 | 16.5 ± 13.6 | 18.4 ± 14.6 | 15.1 ± 12.4 | 16.4 ± 12.5 | 16.5 ± 14.2 | 18.2 ± 14.4 |
| PTV Int D95% [cGy] | 34 | 6081 ± 135 | 6082 ± 137 | 6085 ± 144 | 6054 ± 157 | 6062 ± 156 | 6087 ± 138 | 6095 ± 139 |
| PTV Low D95%[cGy] | 38 | 5611 ± 73 | 5633 ± 81 | 5636 ± 82 | 5629 ± 76 | 5631 ± 74 | 5648 ± 100 | 5637 ± 82 |
| Brainstem Dmax [cGy] | 38 | 3278 ± 1265 | 3194 ± 1203 | 3198 ± 1192 | 3160 ± 1173 | 3170 ± 1195 | 3180 ± 1192 | 3179 ± 1192 |
| Cochlea L Dmean [cGy] | 39 | 1179 ± 1325 | 935 ± 994 | 968 ± 1074 | 858 ± 776 | 580 ± 463 | 981 ± 1076 | 877 ± 757 |
| Cochlea R Dmean [cGy] | 39 | 1344 ± 1192 | 992 ± 872 | 1027 ± 965 | 1053 ± 1016 | 605 ± 359 | 960 ± 864 | 988 ± 822 |
| Constrictors Dmean [cGy] | 36 | 4960 ± 1041 | 4812 ± 1158 | 4782 ± 1171 | 4772 ± 1214 | 4921 ± 1106 | 4819 ± 1139 | 4898 ± 1100 |
| Cord Dmax [cGy] | 39 | 3566 ± 636 | 3594 ± 359 | 3606 ± 354 | 3594 ± 351 | 3548 ± 374 | 3577 ± 408 | 3596 ± 361 |
| Eye L Dmax [cGy] | 26 | 823 ± 1243 | 648 ± 874 | 664 ± 895 | 603 ± 756 | 628 ± 828 | 689 ± 958 | 623 ± 828 |
| Eye R Dmax [cGy] | 26 | 886 ± 1390 | 797 ± 1255 | 805 ± 1250 | 794 ± 1229 | 793 ± 1282 | 808 ± 1260 | 815 ± 1265 |
| Larynx Dmean [cGy] | 27 | 4065 ± 1444 | 3779 ± 1463 | 3728 ± 1470 | 3707 ± 1463 | 3792 ± 1450 | 3851 ± 1463 | 3769 ± 1480 |
| Lips Dmean [cGy] | 5 | 1473 ± 497 | 1614 ± 625 | 1621 ± 610 | 1715 ± 651 | 1750 ± 647 | 1707 ± 718 | 1579 ± 575 |
| Mandible Dmax[cGy] | 38 | 6771 ± 964 | 6777 ± 1079 | 6806 ± 1085 | 6748 ± 1119 | 6786 ± 1085 | 6809 ± 1072 | 6780 ± 1075 |
| Optic Chiasm Dmax [cGy] | 24 | 731 ± 1372 | 680 ± 1312 | 685 ± 1323 | 687 ± 1335 | 681 ± 1331 | 713 ± 1355 | 693 ± 1332 |
| Optic Nerve L Dmax [cGy] | 22 | 926 ± 1432 | 763 ± 1228 | 753 ± 1222 | 770 ± 1252 | 757 ± 1217 | 755 ± 1216 | 759 ± 1222 |
| Optic Nerve R Dmax [cGy] | 23 | 963 ± 1642 | 821 ± 1464 | 814 ± 1445 | 826 ± 1461 | 822 ± 1465 | 811 ± 1457 | 814 ± 1456 |
| Oral Cavity Dmean [cGy] | 38 | 3717 ± 1205 | 3791 ± 1176 | 3804 ± 1186 | 3798 ± 1160 | 3781 ± 1163 | 3800 ± 1186 | 3786 ± 1197 |
| Parotid L Dmean [cGy] | 37 | 2211 ± 900 | 2286 ± 852 | 2260 ± 830 | 2282 ± 912 | 2293 ± 930 | 2251 ± 840 | 2276 ± 837 |
| Parotid L V2600cGy [%] | 37 | 32 ± 18 | 33 ± 17 | 32 ± 17 | 33 ± 18 | 33 ± 18 | 32 ± 17 | 33 ± 17 |
| Parotid R Dmean [cGy] | 36 | 2374 ± 844 | 2419 ± 752 | 2417 ± 767 | 2462 ± 825 | 2479 ± 821 | 2418 ± 746 | 2426 ± 760 |
| Parotid R V2600cGy [%] | 36 | 35 ± 15 | 36 ± 14 | 36 ± 14 | 38 ± 17 | 38 ± 17 | 36 ± 13 | 36 ± 14 |
| Submandibular L Dmean [cGy] | 29 | 4245 ± 1961 | 4307 ± 1792 | 4286 ± 1951 | 4441 ± 1797 | 4494 ± 1674 | 4309 ± 1780 | 4199 ± 1909 |
| Submandibular R Dmean [cGy] | 20 | 4178 ± 1569 | 4232 ± 1570 | 4219 ± 1486 | 4254 ± 1557 | 4262 ± 1486 | 4120 ± 1473 | 4100 ± 1590 |
Note: Overview of dosimetric parameters across the entire patient cohort for the clinical plans, and plans re‐planned with KBPFull , KBP101 , KBP50 , KBP25 , KBPA , and KBPB . Values given as mean ± standard deviation across the 39 plans.